Friday, Texas-based biotech company Vaxxinity (NASDAQ:VAXX) closed up an unbelievable 84% higher. Specifically, VAXX stock skyrocketed on news that it has completed an important milestone in its treatment for Parkinson’s Disease.
So, what do you need to know about Vaxxinity today?
The post Why Did Vaxxinity (VAXX) Stock Gain 80% Today? originally appeared at InvestorPlace.